The United States is responsible for around eighty percent of the world's total consumption of opioids, as stated by the American Society of Interventional Pain Physicians. It was reported in May 2015 by the American Gastroenterological Association that chronic constipation affects one in six people in the United States and is the third-leading symptom that prompts outpatient clinic visits in the country. The article was published in the American Gastroenterological Association. Overweight women are disproportionately affected by this condition. Europe has a high acuity information system, a high degree of disposable wealth, and widespread acceptance of unhealthy lifestyle choices, all of which combine to make it a potential high growth market. The Asia-Pacific region is also anticipated to be a lucrative market for the treatment of constipation. This is mostly owing to the region's expanding westernization, which is defined by the region's rising acceptance of non-nutritious fast food.
The major players operating in Constipation Treatment Market include AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Valeant Pharmaceuticals International, Inc., C.B. Fleet Company Inc., Daewoong Co. Ltd., Sucampo Pharmaceuticals Inc., Cosmo Pharmaceuticals, Synergy Pharmaceuticals Inc. Boehringer Ingelheim GmbH, and Ironwood Pharmaceuticals.
Key Competitors in the Constipation Treatment Industry:
1. Astrazeneca plc
Astrazeneca plc was founded in 1999 and its headquarter Cambridge, United Kingdom. The company operates in 15 countries.
2.takeda Pharmaceutical Company Limited,,
takeda Pharmaceutical Company Limited, founded in 1781, and it’s located in Doshomachi, Osaka, Japan The company operates in 80 Countries. In2018 Takeda Pharmaceutical Company Limited today announced options for the treatment of chronic idiopathic constipation
3. valeant pharmaceuticals headquarters
valeant pharmaceuticals headquarters was launch in 1959and it’s headquarter located in Santa Clara, California, United States .it operate over 110 country and. In 2021 Constipation Treatment Drug Market detailed analysis of a business is mainly covered by Valeant Pharmaceuticals International.
4 C.B. Fleet Company Inc
C.B. Fleet Company Inc was launch in 1936 and it’s headquarter located St. Joseph, Michigan, United States.it operate over 82 country.
5 Daewoong Co. Ltd.
Daewoong Co. Ltd. was founded in1945, with its headquarters in Seoul, South Korea.With businesses in over 42 countries. ..
6.Sucampo Pharmaceuticals Inc
Sucampo Pharmaceuticals Inc Was launch in 1996. and its headquarter Rockville, Maryland, United States. it operate over 50 country. In2021 Sucampo and Abbott Announce Launch of AMITIZA in Japan Product is Japan's Only Prescription Medicine for Chronic Constipation
7. Cosmo Pharmaceuticals
Cosmo Pharmaceuticals was launch in 1997 and it’s headquarter located Ireland.it operate over 56 country.
8. Synergy Pharmaceuticals Inc.
Synergy Pharmaceuticals Inc. Was launch in 1992. And its headquarter Chicago, Illinois, United States. It operate over 50 country.In 2021 Synergy Pharmaceuticals Announces FDA Approval of TRULANCE® (Plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults.
Definition- Constipation is a condition that makes it difficult to evacuate waste from the bowels and typically results in the formation of feces that are hardened.
